口服质子泵抑制剂对五种上消化道内镜治疗延迟出血风险的影响
这项基于日本全国数据库的人群队列研究纳入172,635例患者,采用倾向性评分匹配比较口服PPI与无抑酸治疗在五种上消化道内镜操作后延迟出血的风险。结果显示PPI显著降低胃EMR(OR 0.66)和胃ESD(OR 0.39)的延迟出血风险,但对食管EMR、食管ESD和PEG无显著效果。
要点
- 口服PPI可降低胃EMR和胃ESD后延迟出血风险
- PPI对食管EMR、食管ESD及PEG后延迟出血无显著预防作用
- 不同内镜操作应个体化决定是否使用PPI预防出血
核心结论
- 口服PPI可降低胃EMR和胃ESD后的延迟出血风险,但对食管EMR、食管ESD和PEG无此效应。
研究设计与样本
- 基于日本诊断程序组合数据库的人群队列研究,纳入2012至2022年间接受五种上消化道内镜操作并处方PPI或无抑酸治疗的患者,共172,635例。
主要发现
- 倾向性评分匹配后,PPI组胃EMR的延迟出血风险显著低于无抑酸组(OR 0.66,95%CI 0.52-0.84)。
- PPI组胃ESD的延迟出血风险显著低于无抑酸组(OR 0.39,95%CI 0.30-0.50)。
- 食管EMR(OR 1.05,95%CI 0.56-1.99)、食管ESD(OR 1.09,95%CI 0.86-1.38)和PEG(OR 1.03,95%CI 0.93-1.13)中未观察到PPI降低延迟出血风险。
- 亚组和敏感性分析基本一致地证实了主要结果。
临床怎么用
- 对于胃EMR和胃ESD患者,可考虑口服PPI以降低延迟出血风险。
- 对于食管EMR、食管ESD和PEG患者,不应常规期望通过口服PPI来预防延迟出血。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Although proton-pump inhibitor (PPI) is often prescribed for reducing delayed bleeding in upper gastrointestinal endoscopic treatments, no studies with a sufficient sample size evaluated its reduced effect compared with the absence of acid-suppressive agents. The aim of this study was to investigate the effect of oral PPI on reducing delayed bleeding in 5 upper gastrointestinal endoscopic treatments. METHODS: This population-based cohort study collected data from patients who were either prescribed with PPIs or received no acid-suppressive therapy and who underwent esophageal endoscopic mucosal resection (E-EMR), esophageal endoscopic submucosal dissection (E-ESD), gastric endoscopic mucosal resection (G-EMR), gastric endoscopic submucosal dissection (G-ESD), or percutaneous endoscopic gastrostomy (PEG) in Japan between 2012 and 2022 from the Diagnosis Procedure Combination database. The primary outcome was delayed bleeding in each procedure. We conducted propensity score matching to balance 2 comparison groups and performed logistic regression analyses to compare bleeding outcomes. RESULTS: This study included data on 172,635 patients. After propensity score matching, the delayed bleeding risk with PPI use was significantly lower in G-EMR (odds ratio [OR], 0.66; 95% confidence interval [CI], 0.52-0.84) and G-ESD (OR, 0.39; 95% CI, 0.30-0.50). By contrast, a lower delayed bleeding risk of PPI was not observed in E-EMR (OR, 1.05; 95% CI, 0.56-1.99), E-ESD (OR, 1.09; 95% CI, 0.86-1.38), and PEG (OR, 1.03; 95% CI, 0.93-1.13). The subgroup and sensitivity analyses almost consistently confirmed the main results. DISCUSSION: Oral PPI administration contributed to reducing delayed bleeding risk in G-EMR and G-ESD but not in E-EMR, E-ESD, and PEG.
引用
- Abe H, Hatta W, Tarasawa K, et al. Effect of Oral Proton-Pump Inhibitor Administration on Reducing the Delayed Bleeding Risk in 5 Upper Gastrointestinal Endoscopic Treatments. Am J Gastroenterol. 2025. PMID: 40844513. doi:10.14309/ajg.0000000000003746
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。